Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Estrem currently holds 10,000 shares of MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Estrem has been a net buyer of MLNT stock. They have purchased $50.0K and sold $0 worth of shares.
Paul Estrem's most recent insider trade was on May 29, 2018, when they purchased 10,000 shares at $5.00 per share.
Paul Estrem serves as Executive at MELINTA THERAPEUTICS, INC. /NEW/ (MLNT). They have executed 1 insider transactions totaling $50.0K over their tenure at the company.
Paul Estrem holds the position of Executive at MELINTA THERAPEUTICS, INC. /NEW/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Paul Estrem has shown a buying trading pattern, with $50.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Paul Estrem was on May 29, 2018, when they purchased $50.0K worth of MLNT shares. This transaction involved 10,000 shares at $5.00 per share.
Paul Estrem currently owns 10,000 shares of MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Estrem's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Estrem has 1 Form 4 filings on record as an insider at MELINTA THERAPEUTICS, INC. /NEW/.
Set alerts for Paul Estrem and 40,000+ other insiders.